financetom
Business
financetom
/
Business
/
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
Nov 20, 2024 7:41 PM

05:02 PM EST, 11/20/2024 (MT Newswires) -- (Updates the stock change in the last paragraph.)

Nvidia ( NVDA ) reported fiscal Q3 non-GAAP earnings late Wednesday of $0.81 per diluted share, up from $0.40 a year earlier.

Analysts polled by FactSet expected $0.75 excluding some items.

Revenue in the three months ended Oct. 27 rose to $35.08 billion from $18.12 billion a year earlier.

Analysts surveyed by FactSet expected $33.17 billion.

The company expects fiscal Q4 revenue of $37.5 billion, plus or minus 2%. Analysts expect $37.09 billion.

Nvidia ( NVDA ) shares fell 0.7% in after-hours activity, paring earlier losses.

Price: 144.81, Change: -1.08, Percent Change: -0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pacific Premier Bancorp Insider Sold Shares Worth $720,691, According to a Recent SEC Filing
Pacific Premier Bancorp Insider Sold Shares Worth $720,691, According to a Recent SEC Filing
Sep 11, 2024
06:01 PM EDT, 09/10/2024 (MT Newswires) -- Edward Earl Wilcox, President & COO, on September 09, 2024, sold 30,499 shares in Pacific Premier Bancorp ( PPBI ) for $720,691. Following the Form 4 filing with the SEC, Wilcox has control over a total of 255,939 shares of the company, with 230,592 shares held directly and 25,347 controlled indirectly. SEC Filing:...
Novo Nordisk experimental obesity pill has mild-to-moderate side effects in early trial
Novo Nordisk experimental obesity pill has mild-to-moderate side effects in early trial
Sep 11, 2024
* Amycretin side-effects similar to other incretin-based treatments, mainly gastrointestinal * Decision on Phase III trial pending subcutaneous study data next year * Amycretin showed 13.1% weight loss in Phase I trial By Jacob Gronholt-Pedersen and Maggie Fick COPENHAGEN, Sept 11 (Reuters) - Novo Nordisk's highly anticipated experimental weight-loss pill amycretin was safe and tolerable for patients in an early-stage...
Convicted Nikola founder Milton owes electric truck maker $168 million, judge rules
Convicted Nikola founder Milton owes electric truck maker $168 million, judge rules
Sep 11, 2024
Sept 10 (Reuters) - A U.S. judge said Trevor Milton, the Nikola ( NKLA ) founder who was sentenced to four years in prison after being convicted of fraud, must pay the electric truck maker $167.7 million for making false and misleading statements about the company to the public. In a decision on Monday, U.S. District Judge Diane Humetewa in...
Pacific Premier Bancorp Insider Sold Shares Worth $265,749, According to a Recent SEC Filing
Pacific Premier Bancorp Insider Sold Shares Worth $265,749, According to a Recent SEC Filing
Sep 11, 2024
06:01 PM EDT, 09/10/2024 (MT Newswires) -- Jeff C Jones, Director, on September 09, 2024, sold 11,251 shares in Pacific Premier Bancorp ( PPBI ) for $265,749. Following the Form 4 filing with the SEC, Jones has control over a total of 132,286 shares of the company, with 8,492 shares held directly and 123,794 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1028918/000102891824000111/xslF345X05/wk-form4_1726005538.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved